Kymera Therapeutics, Inc. (KYMR)

CIK 1815442 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kymera Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 2026SCHEDULE 13G/A0000080255-26-000601
Sep 4, 20261440001193125-26-383667
Sep 4, 202640001193125-26-383874
Sep 2, 20261440001950047-26-009024
Aug 14, 2026SCHEDULE 13G/A0000080255-26-000572
Aug 13, 2026SCHEDULE 13G/A0001628098-26-000009
Aug 5, 20268-K0001193125-26-333834
Aug 5, 202610-Q0001193125-26-333849
Jul 27, 202640001193125-26-318408
Jul 27, 20268-K0001193125-26-318078
Jul 27, 202630001193125-26-318404
Jul 7, 202640001193125-26-297817
Jul 7, 20261440001969223-26-000769
Jul 2, 202640001193125-26-295088
Jul 2, 202640001193125-26-295089
Jul 2, 20261440001969223-26-000752
Jul 2, 20264/A0001451612-26-000022
Jul 2, 202640001193125-26-295090
Jul 1, 20261440001950047-26-006765
Jun 30, 202640001451612-26-000018
Jun 30, 20261440001950047-26-006647
Jun 30, 202640001451612-26-000020
Jun 29, 20261440001628280-26-046097
Jun 29, 20261440001628280-26-046098
Jun 26, 20261440000921895-26-001685